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Influence of tobacco use 
on postoperative opiate 
analgesia requirements 
in patients undergoing 
coronary artery bypass graft 
surgery
ABSTRACT
Introduction. The objective of this study was to test the hypothesis that tobacco use status is independently associated with 
postoperative opioid requirements in patients undergoing coronary artery bypass grafting (CABG) when important demograp-
hic variables such as age and gender are taken into account.
Methods. A retrospective chart review of patients who underwent CABG surgery over a one year period at Mayo Clinic in 
Rochester, MN was performed.  Tobacco users (N=69) were compared to nonusers (N=345) with regards to opiate require-
ments and the occurrence of severe pain during the first 48 hours postoperatively.  For comparison, all postoperative opiates 
were converted to oral morphine equivalents (OME).  Adjusted analysis for age and gender was also performed.
Results. Tobacco users were younger than nonusers (P < 0.001), and a greater proportion of former users were male compa-
red to never users (P = 0.003).  Tobacco users had greater mean opiate requirements 401 ± 284 than nonusers 314 ± 240 
mg OME, (P = 0.009).  However, the association between tobacco use and greater postoperative opiate requirements lost 
significance after adjustment for age and gender.  Tobacco use was not associated with increased risk of the development 
of severe pain (P = 0.51).
Conclusions. Although current tobacco users undergoing CABG surgery utilize more opioid analgesics in the first 48 hours 
following extubation than nonusers of tobacco, when adjusted for age and gender, tobacco use was not independently asso-
ciated with differences in postoperative opioid use.
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Introduction
Nicotine can produce analgesia in both 
smokers and non-smokers, (1) and 
specifically produces modest posto-
perative analgesia in non-smokers, 
(2-4) but apparently not in smokers. (5) 
Chronic exposure to nicotine among 
tobacco users may also affect pain 
perception.  For example, patients with 
chronic pain disorders who use tobacco 
report greater pain intensity and functi-
onal impairment compared with those 
who do not use tobacco. (6-8) Regar-
ding acute pain, several studies have 
suggested that smokers have greater 
postoperative pain (9) and increased 
postoperative opioid requirements (10-
12) than nonsmokers.  Creekmore et al. 
demonstrated that smokers undergo-
ing coronary artery bypass graft surge-
ry (CABG) required more postoperative 
opioids than nonsmokers (33% greater 
opioid requirements adjusted for body 
mass index). (11) Limitations of these 
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studies (small sample sizes, heteroge-
nous surgical populations, and others) 
precluded meaningful adjustment for 
variables such as age (13-15) and gen-
der (16,17) which are known to stron-
gly influence postoperative pain. Thus, 
the association between smoking and 
higher postoperative opiate require-
ments is unclear.
The objective of this study was to test 
the hypothesis that tobacco use status 
is independently associated with posto-
perative opioid requirements in pati-
ents undergoing CABG when important 
demographic variables such as age 
and gender are taken into account.
Materials and Methods
The Mayo Clinic Institutional Review 
Board approved this study.  In accor-
dance with Minnesota law, only patients 
that had provided preauthorization for 
the use of their medical record in rese-
arch were included (>95% of Mayo 
patients).  Using the Mayo Clinic Car-
diac Surgical Registry, we identified all 
patients that underwent CABG surgery 
via a primary sternotomy and had an 
endoscopically harvested sapheno-
us vein graft during the time period of 
January 1st 2007 thru December 31st 
2007.  This vein grafting procedure 
produces minimal incisional pain at 
the site of harvest. Exclusion criteria 
included lack of data regarding current 
self-reported smoking status (never, 
former, or current smoker), prolonged 
endotracheal intubation (more than 12 
hours after skin closure), and cardiac 
re-operation or death within 48 hours 
of extubation. Because incisional pain 
from vessel donor sites could affect 
opioid requirements (18) patients that 
underwent radial artery harvest or open 
saphenous vein harvest were exclu-
ded. Patients receiving intraoperative 
supplementation of anesthesia with 
a ketamine infusion were also exclu-
ded because of the potential for resi-
dual analgesic effects. Patients who 
also underwent valvular replacement 
in addition to their CABG surgery were 
also included.
Information regarding each patient’s 
tobacco use history (current user [wit-
hin 30 days prior to surgery], former 
user, or never user), demographic and 
clinical variables, and intraoperative 
and postoperative opiate analgesics 
used in the first 48 hours postoperative-
ly were recorded.  To make comparison 
between opioid medications, all opi-
oids were converted to oral morphine 
equivalents (table 1) using published 
dose equivalents for opiate analgesics 
guidelines. (19-22) Only one patient, 
a 68 year old male who was taking 
methadone 5 mg three times a day 
for chronic face pain, was administe-
red methadone in the postoperative 
period, a single 5 mg oral dose. For 
this case methadone was converted to 
morphine equivalents using a 1:1 con-
version ratio. Upon arrival to the intensi-
ve care unit, a fentanyl infusion was ini-
tiated at 0.5 mcg/kg/hr and continued 
until extubation. Following extubation, 
typically, patients were administered 
intravenous fentanyl via a patient-con-
trolled analgesia device until they could 
tolerate oral opiate medications and 
then were usually administered either 
oxycodone or tramadol. Patients also 
received scheduled acetaminophen. 
Nursing staff regularly obtain pain 
scores from patients using a numeric 
rating pain scale from 0 – 10, with 0 
being no pain and 10 being maximal 
pain. The use of nicotine replacement 
or varenicline in the postoperative peri-
od was also noted.
Analysis. Statistical analysis was con-
ducted using JMP (version 7.0.1, SAS 
Institute Inc., Cary, NC). Clinical and 
demographic variables were compared 
between groups using Student’s t-test 
continuous variables and the chi-squa-
re test (or Fisher’s exact test) for cate-
gorical variables. Initial analyses were 





Intravenous fentanyl 100 mcg 30
Intravenous sufentanil 12 mcg 30
Intravenous hydromorphone 1.5 mg 30
Intravenous morphine 10 mg 30
Intravenous meperidine 75 mg 30
Intravenous oxymorphone 1 mg 30
Oral oxycodone 20 mg 30
Oral hydrocodone 20 mg 30
Oral methadone* 1 mg 1
Oral tramadol 50 mg 10
* One patient received a single 5 mg dose of methadone.  This patient was a 68-year-old 
male that used methadone 5 mg three times a day for chronic face pain.  We chose a 1:1 
conversion in this instance.
Table 2.  Intraoperative and postoperative oral morphine equivalents (mg) use 










Intra-operative 639 (303) 639 (302) 611 (253) 0.7672
0-48 hours after 
extubation
293 (217) 329 (254) 401 (284) 0.0136
Values are Mean (SD)
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performed with patients categorized 
into three groups (current, past toba-
cco users, and never tobacco users). 
Because past tobacco users and never 
tobacco users had similar postopera-
tive opiate requirements (see below), 
these two groups were combined 
for subsequent multivariate analysis. 
Analysis of covariance (ANCOVA) was 
conducted for post-operative opiate 
requirements using age, gender and 
tobacco use as covariates. Pain was 
considered to be severe if the numeric 
pain score provided by a patient was 
7 or greater. (23,24) The association 
between current tobacco use and the 
risk of experiencing an episode of seve-
re pain was determined with logistic 
regression. A subsequent multivariate 
analysis logistic regression model for 
the development of severe pain was 
also constructed using age, gender 
and tobacco use as covariates. In all 
cases a P value of <0.05 was conside-
red significant.
Results
Four hundred fourteen (414) patients 
underwent coronary artery bypass sur-
gery and received an endoscopically 
harvested saphenous vein graft.  In this 
cohort, 69 patients reported current 
use of tobacco products (within 30 
days prior to the surgery). Fifty-eight 
of the tobacco users used cigarettes 
as their primary tobacco product, with 
the remaining using either chewing 
tobacco or cigars. Tobacco users were 
younger than non-users (61 ± 11 vs 
71 ± 10 years, P < 0.001), but had 
similar gender distribution (78% and 
76% male among users and non-users, 
respectively, P = 0.72). Of the non-
users, 138 reported never using toba-
cco products and 207 reported prior 
use.  Of the former users, 90% reported 
not using tobacco products for greater 
than one year and 71% reported not 
using for greater than 10 years. There 
was no age difference between former 
and never users (70 ± 10 vs 70 ± 11 
years, P = 0.71), but a greater pro-
portion of former smokers were male 
(82% vs 67%, P = 0.003).  The number 
of patients that also underwent a val-
vular procedure during CABG similar 
was similar between tobacco users 
and nonusers (28% vs 27%, P = 0.210). 
Cardiopulmonary bypass times were 
similar among tobacco users and non-
users (95 ± 34 vs 94 ± 32 minutes, P 
= 0.83).
There was no significant difference in the 
amount of intraoperative opioids given 
to the three groups (table 2). Current 
tobacco users received more opioids 
than non-users in the first 48 hours after 
extubation (401 ± 284 mg OME vs 314 
± 240 mg OME, P = 0.009). There 
was a trend for former users to use 
more opioids than never users (table 2), 
but this did not reach statistical signi-
ficance.  However, after adjustment 
for demographic differences (age and 
gender) in multivariable analysis, the 
association between current tobacco 








Current tobacco use + 6.2 -25.6, + 38.0 0.70
Age (decade of life) - 77.5 - 99.6, - 55.4 <0.0001
Female gender - 53.0 - 79.5, - 26.5 0.0001
OME = Oral morphine equivalents.  * Effect estimate corresponds to mean increase or decrease in OME mg associated with 
the given characteristic.
Table 4.  Logistic regression model of the occurrence of post-operative severe pain within the first 48 hours.
Patient characteristic Univariate Analysis Multivariate Analysis
Odds Ratio 95% CI P Odds Ratio 95% CI P
Age (decade of life) 0.10 0.03, 0.27 <0.0001 0.09 0.03, 0.26 <0.0001
Gender 0.180 0.336
   Male 1.00 - 1.00 -
   Female 1.41 0.85, 2.29 1.29 0.77, 2.13
Tobacco Use 0.512 0.398
   Current User 1.00 - 1.00 -
   Current Non-user 0.83 0.47, 1.48 1.30 0.71, 2.46
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use and opioid use in the 48 hours 
after extubation was no longer signi-
ficant (table 3). Post-operatively, 25 
current tobacco users received thera-
py for nicotine dependence (22 rece-
ived nicotine replacement, 6 received 
varenicline, and 3 patients receiving 
both). There was no difference in total 
48 hour opioid used between tobacco 
users that received therapy for nicotine 
dependence compared to those that 
did not (420 ± 275 mg oral morphine 
equivalents [OME] vs 397 ± 291 mg 
OME, P = 0.75). Severe pain (repor-
ted pain scale > 7/10) was reported 
at least once by 82 patients (20%) in 
the first 48 hours after extubation.  The 
odds of experiencing severe pain were 
not influenced by tobacco use with eit-
her univariate or multivariate analysis 
(table 4), but were greater in younger 
patients.
Discussion
The major finding of this study is that 
current tobacco users undergoing 
CABG surgery utilize more opioid anal-
gesics in the first 48 hours following 
extubation than nonusers of tobacco. 
However, when adjusting for age and 
gender, tobacco use was not indepen-
dently associated with differences in 
postoperative opioid use.  A secondary 
finding of this study is that tobacco 
users are not at increased risk for the 
development of severe postoperative 
pain.
Chronic exposure to nicotine and other 
tobacco constituents is associated 
with an increased prevalence of chro-
nic painful conditions in many studies. 
(25,26) Among those with chronic pain, 
smokers report greater pain intensity 
and functional impairment. (7,8) Multi-
ple mechanisms may explain this asso-
ciation, including changes in acetylcho-
line receptor distribution or function in 
response to chronic nicotine exposure. 
On the other hand, nicotine itself can 
produce analgesia when administe-
red acutely, both in smokers and non 
smokers, so that the overall effects of 
tobacco use on pain sensitivity appears 
to be complex and multi-factorial. (1)
Creekmore et al. found that patients 
undergoing CABG surgery demon-
strated that smokers had a 23% gre-
ater opioid requirement in the first 48 
postsurgical hours compared with a 
group of former and never smokers. 
(11) The magnitude of the increased 
opioid requirement was very similar 
to our findings (tobacco users used 
22% more post-operative opioids than 
non-users). However, factors other 
than tobacco use status may affect 
postoperative opioid requirements, 
including patient characteristics such 
as age, gender, and surgical procedu-
ral characteristics. (15) For example, 
multiple studies show that postopera-
tive pain and opiate requirements are 
inversely related to age, (13-15) and 
less in female patients. (16,17) Results 
from our multivariable analysis confirm 
these previous observations that age 
and gender were independently asso-
ciated with postoperative opiate use. 
The younger age of tobacco users in 
our study reflect findings published by 
the Centers for Disease Control which 
shows that smoking rates are much 
lower among Americans over 65 years 
of age (8.3%) compared to the general 
population (19.8%). (27) Thus, the dif-
ferences in opioid requirements asso-
ciated with tobacco use status can be 
explained in part because current users 
were younger.
In addition to not adjusting for age and 
gender, the Creekmore et al. study did 
not provide data regarding surgical 
characteristics that may have influen-
ced postoperative pain. In order to mini-
mize variations in surgical stimulus, 
we limited our cohort to patients that 
underwent endoscopically harvested 
saphenous vein grafts as it was our 
clinical impression that radial artery 
harvest and open saphenous vein har-
vest result in significantly more posto-
perative pain, and internal mammary 
artery harvest does not contribute more 
pain other than that associated with 
sternotomy.
Other studies have found increased 
opioid consumption after surgical pro-
cedures in smokers.  Berge et al. found 
that following third molar extraction, 
those smoking more than 10 cigarettes 
a day used significantly more aceta-
minophen/codeine tablets compared 
with non-smokers and light smokers, 
although the difference was modest 
(mean of 0.6 tablets). (10) In anot-
her study, female former and current 
smokers used more opioid analgesics 
than female never-smokers following 
obstetric and gynecologic surgery. (12) 
However, like the Creekmore study, 
neither study attempted to analyze 
possible covariates that might influence 
opioid consumption.  Details of adjun-
ctive techniques such as regional anal-
gesia were not provided, nor was the 
level of analgesia achieved reported. 
In a general surgical population, smo-
kers reported higher pain scores both 
before and after surgery but did not 
experience greater increases in pain 
postoperatively compared with non-
smokers, (9) although in this study pain 
was only a secondary endpoint, opioid 
consumption was not measured, and a 
wide range of surgical procedures was 
included.  Thus, our study is not directly 
comparable, but we did not find that 
tobacco users were at increased risk of 
severe postoperative pain.
Our study had several significant 
limitations, including all the inherent 
limitations of a retrospective study. 
It also relied on patient self-report of 
tobacco use. Although such reports 
are generally reliable (28) there is the 
possibility that some of the non-users 
were actually using tobacco. Intrao-
perative management of anesthesia, 
including opioid administration, was 
not standardized, although a standar-
dized regimen is followed in our cardiac 
anesthesia practice, as reflected by 
similar use of intraoperative opioids 
among all groups. Postoperative pain 
management was not standardized 
which introduces potential practice 
management differences as a source 
of bias. Furthermore, 25 tobacco users 
received therapy for nicotine withdrawal 
(nicotine replacement and/or varenicli-
ne), although we did not find an associ-
ation between these therapies and opi-
oid use. We did not attempt to exclude 
patients that used sustained release or 
long acting opiate formulations prior to 
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surgery because this information was 
not always available from chart review. 
Because opioid tolerance increases 
postoperative opiate requirements15, 
potential differences between groups 
could have introduced bias. Data on 
the quantity or duration of tobacco use 
was also not available, and it has been 
suggested that heavy smokers have 
higher postoperative opiate require-
ments. (10) We studied only one type 
of surgery, which is an experimental 
strength.  However, these findings may 
not apply to other surgical procedures, 
including those examined in the prior 
studies reviewed. Finally, our institu-
tion is a major referral center and our 
results may not generalize to commu-
nity based patients.
In conclusion, tobacco users undergo-
ing CABG surgery receive more opioids 
postoperatively than non-users, but this 
is primarily a function of the interactions 
between tobacco use and other factors 
known to influence postoperative opi-
oid requirements, specifically younger 
age and male gender. Studies of how 
tobacco use affects postoperative pain 
must adjust for other clinical variables 
that influence postoperative pain.
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